HealthEquity Inc (HQY)vsOmnicell Inc (OMCL)
HQY
HealthEquity Inc
$82.47
+0.45%
HEALTHCARE · Cap: $7.01B
OMCL
Omnicell Inc
$34.94
+1.39%
HEALTHCARE · Cap: $1.57B
Smart Verdict
WallStSmart Research — data-driven comparison
HealthEquity Inc generates 11% more annual revenue ($1.31B vs $1.18B). HQY leads profitability with a 16.4% profit margin vs 0.2%. HQY appears more attractively valued with a PEG of 0.89. HQY earns a higher WallStSmart Score of 68/100 (B-).
HQY
Strong Buy68
out of 100
Grade: B-
OMCL
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+33.2%
Fair Value
$115.13
Current Price
$82.47
$32.66 discount
Margin of Safety
-13907.4%
Fair Value
$0.27
Current Price
$34.94
$34.67 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 92.4% YoY
Growing faster than its price suggests
Strong operational efficiency at 21.6%
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
2.3% revenue growth
Smaller company, higher risk/reward
ROE of 0.2% — below average capital efficiency
0.2% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : HQY
The strongest argument for HQY centers on EPS Growth, PEG Ratio, Operating Margin. Profitability is solid with margins at 16.4% and operating margin at 21.6%. PEG of 0.89 suggests the stock is reasonably priced for its growth.
Bull Case : OMCL
The strongest argument for OMCL centers on Price/Book, Debt/Equity.
Bear Case : HQY
The primary concerns for HQY are P/E Ratio.
Bear Case : OMCL
The primary concerns for OMCL are Revenue Growth, Market Cap, Return on Equity. A P/E of 861.5x leaves little room for execution misses. Thin 0.2% margins leave little buffer for downturns.
Key Dynamics to Monitor
HQY profiles as a mature stock while OMCL is a value play — different risk/reward profiles.
OMCL carries more volatility with a beta of 0.79 — expect wider price swings.
HQY is growing revenue faster at 7.3% — sustainability is the question.
HQY generates stronger free cash flow (102M), providing more financial flexibility.
Bottom Line
HQY scores higher overall (68/100 vs 39/100), backed by strong 16.4% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
HealthEquity Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.
Omnicell Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?